tiprankstipranks
Petros Pharmaceuticals (PTPI)
NASDAQ:PTPI
US Market

Petros Pharmaceuticals (PTPI) Technical Analysis

Compare
138 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Petros Pharmaceuticals’s (PTPI) Moving Averages Convergence Divergence (MACD) indicator is -0.04, suggesting Petros Pharmaceuticals is a Buy.
Petros Pharmaceuticals’s (PTPI) 20-Day exponential moving average is 0.23, while Petros Pharmaceuticals’s (PTPI) share price is $0.12, making it a Sell.
Petros Pharmaceuticals’s (PTPI) 50-Day exponential moving average is 0.28, while Petros Pharmaceuticals’s (PTPI) share price is $0.12, making it a Sell.

Petros Pharmaceuticals (PTPI) Pivot Points

Feb 23, 2025, 11:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.09
0.10
0.12
0.13
0.15
0.16
0.18
Fibonacci
0.10
0.11
0.12
0.13
0.14
0.15
0.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Petros Pharmaceuticals (PTPI) Moving Averages

Feb 23, 2025, 11:19 AM
Period
Simple
Exponential
MA5
0.17Sell
0.16Sell
MA10
0.21Sell
0.19Sell
MA20
0.25Sell
0.23Sell
MA50
0.31Sell
0.28Sell
MA100
0.31Sell
0.33Sell
MA200
0.38Sell
0.47Sell
Petros Pharmaceuticals’s (PTPI) 10-Day exponential moving average is 0.19, while Petros Pharmaceuticals’s (PTPI) share price is $0.12, making it a Sell.
Petros Pharmaceuticals’s (PTPI) 100-Day exponential moving average is 0.33, while Petros Pharmaceuticals’s (PTPI) share price is $0.12, making it a Sell.
Petros Pharmaceuticals’s (PTPI) stock price is $0.12 and Petros Pharmaceuticals’s (PTPI) 50-day simple moving average is 0.31, creating a Sell signal.
Petros Pharmaceuticals’s (PTPI) stock price is $0.12 and Petros Pharmaceuticals’s (PTPI) 100-day simple moving average is 0.31, creating a Sell signal.
Petros Pharmaceuticals’s (PTPI) stock price is $0.12 and Petros Pharmaceuticals’s (PTPI) 200-day simple moving average is 0.38, creating a Sell signal.

Petros Pharmaceuticals (PTPI) Technical Indicators

Feb 23, 2025, 11:19 AM
Name
Value
Implied Action
RSI (14)
29.94
Buy
STOCH (9,6)
2.97
Buy
STOCHRSI (14)
2.97
Buy
MACD (12,26)
-0.04
Buy
ADX (14)
29.11
Neutral
Williams %R
-100.00
Buy
CCI (14)
-178.06
Buy
ATR (14)
0.06
-
Ultimate Oscillator
20.49
Sell
ROC
-57.14
Sell
Petros Pharmaceuticals’s (PTPI) Relative Strength Index (RSI) is 29.94, creating a Buy signal.
Petros Pharmaceuticals’s (PTPI) Trend Strength Indicator (ADX) is 29.11, creating a Neutral signal.
Petros Pharmaceuticals’s (PTPI) Commodity Channel Index (CCI) is -178.06, creating a Buy signal.
Petros Pharmaceuticals’s (PTPI) Price Rate of Change (ROC) is -57.14, creating a Sell signal.

FAQ

Is PTPI a Buy, Hold, or Sell?
Based on PTPI’s technical indicators, PTPI is a Sell.
    What is PTPI’s RSI (14)?
    PTPI’s RSI (14) is 29.94, which suggests PTPI is a Buy.
      What is PTPI’s MACD?
      PTPI’s MACD is -0.04, which suggests PTPI is a Buy.
        What is PTPI’s 5-day moving average?
        PTPI’s 5-day moving average is 0.17, which suggests PTPI is a Sell.
          What is PTPI’s 20-day moving average?
          PTPI 20-day moving average is 0.25, which suggests PTPI is a Sell.
            What is PTPI’s 50-day moving average?
            PTPI’s 50-day moving average is 0.31, which suggests PTPI is a Sell.
              What is PTPI’s 200-day moving average?
              PTPI’s 200-day moving average is 0.38, which suggests PTPI is a Sell.
                What is PTPI’s Williams % R (14)?
                PTPI’s Williams % R (14) is -100.00, which suggests PTPI is a Buy.
                  What is PTPI’s CCI (14)?
                  PTPI’s CCI (14) is -178.06, which suggests PTPI is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis